Global Osteoarthritis Drug Market Report By Drug Class (Corticosteroids, NSAIDs, Viscosupplementation Agents And Others), Route Of Administration (Oral, Parenteral And Topical) Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11211137

January 2020

Report Formats:

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Description
Table Of Content

As per this study, the Global Osteoarthritis Drug Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Osteoarthritis is the type of arthritis; characterized by joint inflammation, joint pain, swelling and stiffness. It is the medical condition, which results from break down of joint cartilage. The osteoarthritis can be treated by life style changes, physical measures, medications, therapies, surgeries or joint replacement.

Market Dynamics

The market is gaining high demand on the account of the rapid increase in the count of the patients suffering from osteoarthritis. The increasing aged population and increase in prevalence of bone diseases and obesity is driving the market growth. The rise in R&D activities, availability of innovative & advanced treatments is further contributing the market growth. On the flip side, the high cost of treatment is likely to hinder the growth of this market.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of osteoarthritis drug.

Market Segmentation

The broad osteoarthritis drug market has been sub-grouped into drug class, route of administration and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Drug Class

Corticosteroids
NSAIDS
Viscosupplementation Agents
Others

By Route Of Administration

Oral
Parenteral
Topical

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regional Analysis

Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for osteoarthritis drug in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Europe Osteoarthritis Drug Market By Revenue (USD MN)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the osteoarthritis drug market include Alkem Laboratories, Anika Therapeutics, Inc., Bioventus, Inc., Chugai Pharmaceutical Co., Limited, Ferring B.V., Horizon Pharma plc, Pfizer Inc., Sanofi, Flexion Therapeutics, Inc. and Zimmer Biomet Holdings, Inc. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Osteoarthritis Drug Market
       2.2. Global Osteoarthritis Drug Market Snapshot

3 . OSTEOARTHRITIS DRUG – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Osteoarthritis Drug Market
       3.3. Market Restraints of Osteoarthritis Drug Market
       3.4. Opportunities of Osteoarthritis Drug Market
       3.5. Trends of Osteoarthritis Drug Market
       3.6. Porter’s Five Force Analysis of Osteoarthritis Drug Market
       3.7. Osteoarthritis Drug Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Class
           3.7.2 Market Attractive Analysis by Route Of Administration
           3.7.3 Market Attractive Analysis by By Distribution Channel
           3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Osteoarthritis Drug Value Chain Analysis
       4.2. Osteoarthritis Drug Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Osteoarthritis Drug Raw Material Manufactures List
           4.2.3. Price Trend of Osteoarthritis Drug Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL OSTEOARTHRITIS DRUG MARKET ANALYSIS BY DRUG CLASS
       5.1 Overview by Drug Class
       5.2 Global Osteoarthritis Drug Market Analysis by Drug Class
       5.3 Market Analysis of Corticosteroids by Regions
       5.4 Market Analysis of NSAIDS by Regions
       5.5 Market Analysis of Viscosupplementation Agents by Regions
       5.6 Market Analysis of Others by Regions

6 . GLOBAL OSTEOARTHRITIS DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       6.1 Overview by Route Of Administration
       6.2 Global Osteoarthritis Drug Market Analysis by Route Of Administration
       6.3 Market Analysis of Oral by Regions
       6.4 Market Analysis of Parenteral by Regions
       6.5 Market Analysis of Topical by Regions

7 . GLOBAL OSTEOARTHRITIS DRUG MARKET ANALYSIS BY BY DISTRIBUTION CHANNEL
       7.1 Overview by By Distribution Channel
       7.2 Global Osteoarthritis Drug Market Analysis by By Distribution Channel
       7.3 Market Analysis of Hospital Pharmacies by Regions
       7.4 Market Analysis of Retail Pharmacies by Regions
       7.5 Market Analysis of Online Pharmacies by Regions

8 . GLOBAL OSTEOARTHRITIS DRUG MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Osteoarthritis Drug Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Osteoarthritis Drug Market Estimate by Market Segment
           8.4.3. Europe Osteoarthritis Drug Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Osteoarthritis Drug Market Estimate by Market Segment
           8.5.3. Asia Pacific Osteoarthritis Drug Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Osteoarthritis Drug Market Estimate by Market Segment
           8.6.3. Latin America Osteoarthritis Drug Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Osteoarthritis Drug Market Estimate by Market Segment
           8.7.3. Middle East & Africa Osteoarthritis Drug Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE OSTEOARTHRITIS DRUG COMPANIES
       9.1. Osteoarthritis Drug Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF OSTEOARTHRITIS DRUG INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Alkem Laboratories
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Anika Therapeutics, Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Bioventus, Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Chugai Pharmaceutical Co., Limited
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Ferring B.V.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Horizon Pharma plc.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
      10.9. Pfizer Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Sanofi, Flexion Therapeutics, Inc.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Zimmer Biomet Holdings, Inc.
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK
11.1. Impact Analysis of Covid-19 Outbreak on Osteoarthritis Drug Market
11.1.1. Direct Impact on Production
11.1.2. Supply Chain and Market Disruption
11.1.3. Financial Impact on Firms and Financial Markets
11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
11.3. Osteoarthritis Drug Market: Pre V/S Post COVID-19 Market
11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Osteoarthritis Drug Market Size in 2020, by Scenario
11.5. COVID-19: Micro and Macro Factor Analysis on Osteoarthritis Drug Market

*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Osteoarthritis Drug Report
Market Research Process
Market Research Methodology
Global Osteoarthritis Drug Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Drug Class
Market Attractiveness Analysis by Route Of Administration
Market Attractiveness Analysis by By Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
Global Osteoarthritis Drug Market Analysis in Corticosteroids by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis in NSAIDS by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis in Viscosupplementation Agents by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis in Others by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis by Route Of Administration (USD MN)
Global Osteoarthritis Drug Market Analysis in Oral by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis in Parenteral by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis in Topical by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis by By Distribution Channel (USD MN)
Global Osteoarthritis Drug Market Analysis in Hospital Pharmacies by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis in Retail Pharmacies by Geography (USD MN)
Global Osteoarthritis Drug Market Analysis in Online Pharmacies by Geography (USD MN)
Latin America Osteoarthritis Drug Market by Revenue
Middle East & Africa Osteoarthritis Drug Market by Revenue
Recent Development in Osteoarthritis Drug Industry
Company Market Share Analysis, 2019

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

ID:VMR11211137

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

ID:VMR11211137

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

Important: Covid19 pandemic market impact